azathioprine has been researched along with Dysgeusia in 2 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bozzalla Cassione, E | 1 |
Zanframundo, G | 1 |
Biglia, A | 1 |
Codullo, V | 1 |
Montecucco, C | 1 |
Cavagna, L | 1 |
Ellul, P | 1 |
Vella, V | 1 |
Vassallo, M | 1 |
2 other studies available for azathioprine and Dysgeusia
Article | Year |
---|---|
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Labora | 2020 |
Reversible dysgeusia attributed to azathioprine.
Topics: Aged; Azathioprine; Colitis, Ulcerative; Colonoscopy; Dysgeusia; Follow-Up Studies; Humans; Immunosu | 2007 |